Research on nanodelivery systems for nasal vaccine

Research on nanodelivery systems for nasal vaccine

L'administration nasale a un grand avantage pour stimuler l'immunité protectrice locale et systémique. Cependant, des systèmes d'administration et des adjuvants sont souvent nécessaires pour améliorer l'efficacité du vaccin intranasal. Nous avons appliqué la technologie des nanop...

Full description

Bibliographic Details
Main Author:	Le, Minh Quan
Other Authors:	Lille 2
Language:	en
Published:	2018
Subjects:	Nanoparticules Délivrance Administration intranasale Vaccin Grippe Nanoparticles Intranasal vaccine delivery Influenza Mucoadhesive
Online Access:	http://www.theses.fr/2018LIL2S020/document

Similar Items

Nouveau système de délivrance d'antigènes à base de nanoparticules lipidiques (Lipidots) pour formulation vaccinale
by: Bayon, Emilie
Published: (2018)

Intranasal Delivery of a Chitosan-Hydrogel Vaccine Generates Nasal Tissue Resident Memory CD8<sup>+</sup> T Cells That Are Protective against Influenza Virus Infection
by: James G. Bedford, et al.
Published: (2020-10-01)

Systèmes nanostructurés décorés par du chitosane pour la délivrance buccale de la curcumine
by: Mazzarino, Leticia
Published: (2013)

Développement et évaluation pré-clinique de nouveaux vaccins inactivés contre l’influenza et suivi de l’évolution des souches virales A/H3N2
by: Ann, Julie
Published: (2015)

Porous maltodextrin nanoparticles for the intranasal delivery of vaccines
by: Bernocchi, Beatrice
Published: (2016)

Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections
by: Cynthia Calzas, et al.
Published: (2019-07-01)

Engineered Nanodelivery Systems to Improve DNA Vaccine Technologies
by: Michael Lim, et al.
Published: (2020-01-01)

Évaluation des pseudo-particules grippales dans un but de vaccination par voies muqueuses
by: Pereau Buffin, Sophie
Published: (2019)

Immunogenicity Evaluation of Recombinant Staphylococcus aureus Enterotoxin B (rSEB) and rSEB-loaded Chitosan Nanoparticles Following Nasal Administration
by: Seyed Amir Hosseini, et al.
Published: (2020-04-01)

La mucosa nasal como vía y fuente para la medicina regenerativa Nasal mucosa as pathway and source for regenerative medicine
by: Porfirio Hernández-Ramírez
Published: (2011-09-01)

Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs
by: Santosh Dhakal, et al.
Published: (2018-05-01)

Safety and Efficacy of Spray Intranasal Live Attenuated Influenza Vaccine: Systematic Review and Meta-Analysis
by: Giulia Perego, et al.
Published: (2021-09-01)

Sommaire de la Déclaration du CCNI sur la vaccination antigrippale pour la saison 2020–2021
by: Kelsey Young, et al.
Published: (2020-05-01)

Comparative evaluation of intranasally delivered quetiapine loaded mucoadhesive microemulsion and polymeric nanoparticles for brain targeting: pharmacokinetic and gamma scintigraphy studies
by: Brijesh Shah, et al.
Published: (2021-01-01)

Intranasal Administration of RBD Nanoparticles Confers Induction of Mucosal and Systemic Immunity against SARS-CoV-2
by: Tuksin Jearanaiwitayakul, et al.
Published: (2021-07-01)

Intranasal vaccination with an engineered influenza virus expressing the receptor binding subdomain of botulinum neurotoxin provides protective immunity against botulism and influenza
by: Junwei eLi, et al.
Published: (2015-04-01)

Formulation and kinetic modeling of curcumin loaded intranasal mucoadhesive microemulsion
by: B Mikesh Patel, et al.
Published: (2012-01-01)

Contribution méthodologique à l’évaluation médicoéconomique des programmes de vaccination
by: Aballéa, Samuel
Published: (2015)

mRNA Vaccines Encoding the HA Protein of Influenza A H1N1 Virus Delivered by Cationic Lipid Nanoparticles Induce Protective Immune Responses in Mice
by: Xinyu Zhuang, et al.
Published: (2020-03-01)

New Opportunity to Formulate Intranasal Vaccines and Drug Delivery Systems Based on Chitosan
by: Roxana Popescu, et al.
Published: (2020-07-01)

Nanoparticles as Adjuvants and Nanodelivery Systems for mRNA-Based Vaccines
by: Iman M. Alfagih, et al.
Published: (2021-12-01)

Systemic and Mucosal Antibody Responses to Soluble and Nanoparticle-Conjugated Antigens Administered Intranasally
by: Savannah E. Howe, et al.
Published: (2016-10-01)

Safety and Immunogenicity of a Novel Intranasal Influenza Vaccine (NasoVAX): A Phase 2 Randomized, Controlled Trial
by: Sybil Tasker, et al.
Published: (2021-03-01)

Liposomal nanoparticle-based conserved peptide influenza vaccine and monosodium urate crystal adjuvant elicit protective immune response in pigs
by: Dhakal S, et al.
Published: (2018-10-01)

Efficacité post autorisation de mise sur le marché de la vaccination antigrippale saisonnière contre l’hospitalisation avec une grippe confirmée virologiquement chez l’adulte en Europe
by: Rondy, Marc
Published: (2017)

Intranasal administration of inactivated avian influenza virus of H5N1 subtype vaccine-induced systemic immune response in chicken and mice
by: I N. Suartha, et al.
Published: (2018-02-01)

Development and clinical translation of microneedles for insulin delivery and self-vaccination
by: Norman, James Jefferis
Published: (2015)

Promising Adjuvants and Platforms for Influenza Vaccine Development
by: Wandi Zhu, et al.
Published: (2021-01-01)

Emulsions structurées et nanoparticules magnétiques dans un hydrogel : réalisation, caractérisation et validation en tant que système de délivrance thermomagnétique
by: Milosevic-Markovic, Irena
Published: (2009)

Pre-Clinical Toxicity Study and Safety Assessment of Candidate Live Pertussis Vaccine for Intranasal Administration
by: L. N. Sinyashina, et al.
Published: (2019-01-01)

Pre-clinical study of protective potency of candidate recombinant live pertussis vaccine for intranasal administration
by: L. N. Sinyashina, et al.
Published: (2019-08-01)

Épidémiologie des réactions d'allure allergique au vaccin contre la grippe pandémique A(H1N1)pdm09
by: Rouleau, Isabelle, et al.
Published: (2014)

Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives
by: Yingying Xu, et al.
Published: (2014-07-01)

Démontrer la capacité du Comité consultatif national de l’immunisation à réagir rapidement aux signaux de surveillance des vaccins après leur mise sur le marché : l’expérience du Canada avec le vaccin antigrippal vivant atténué
by: Linlu Zhao, et al.
Published: (2021-05-01)

Shortcut Approaches to Substance Delivery into the Brain Based on Intranasal Administration Using Nanodelivery Strategies for Insulin
by: Toshihiko Tashima
Published: (2020-11-01)

Endocytic Uptake of Solid Lipid Nanoparticles by the Nasal Mucosa
by: Ammar S. Al Khafaji, et al.
Published: (2021-05-01)

Development of Different Methods for Preparing Acinetobacter baumannii Outer Membrane Vesicles Vaccine: Impact of Preparation Method on Protective Efficacy
by: Sun Li, et al.
Published: (2020-06-01)

Chemical Conjugation Strategies for the Development of Protein-Based Subunit Nanovaccines
by: Lantian Lu, et al.
Published: (2021-05-01)

Gellan gum-based mucoadhesive microspheres of almotriptan for nasal administration: Formulation optimization using factorial design, characterization, and in vitro evaluation
by: Zaheer Abbas, et al.
Published: (2014-01-01)

Immunity and Protective Efficacy of Mannose Conjugated Chitosan-Based Influenza Nanovaccine in Maternal Antibody Positive Pigs
by: Sankar Renu, et al.
Published: (2021-03-01)